EichorEICHOR
Location: Greenwich Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Greenwich

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Velocity Clinical Research, Providence (East Greenwich) · AbbVie · NCT06602479
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Coastal Eye Surgeons · Astellas Pharma Global Development, Inc. · NCT06779773
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · NRG Oncology · NCT05174169
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · Alliance for Clinical Trials in Oncology · NCT06876714
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT05806515
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · Coastal Eye Surgeons · Kodiak Sciences Inc · NCT06990399
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT05256225
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · ECOG-ACRIN Cancer Research Group · NCT04566328
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · NRG Oncology · NCT04852887
SORE Study: Sitz Baths After Urogynecologic Reconstruction
NA · Greenwich Hospital · Yale University · NCT07215780
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT06058377
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Smilow Cancer Hospital Care Center at Greenwich · ECOG-ACRIN Cancer Research Group · NCT04239573
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT05987241
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT04205968
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT06022939
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT05675410
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · Smilow Cancer Hospital Care Center at Greenwich · ECOG-ACRIN Cancer Research Group · NCT02734537
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Gandelman Cardiology, PC · Amgen · NCT07136012
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT06616584
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT03723928
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · ECOG-ACRIN Cancer Research Group · NCT06475989
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Phase 3 · Incyte Corporation · NCT06548360
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Diffe
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT06422806
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT04267848
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · ECOG-ACRIN Cancer Research Group · NCT03937635
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · NRG Oncology · NCT07166406
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Out
Phase 2 · Smilow Cancer Hospital Care Center at Greenwich · National Cancer Institute (NCI) · NCT06050252
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · Smilow Cancer Hospital Care Center at Greenwich · NRG Oncology · NCT04251052
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · Smilow Cancer Hospital Care Center at Greenwich · NRG Oncology · NCT06580314
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · Smilow Cancer Hospital Care Center at Greenwich · SWOG Cancer Research Network · NCT05642572
Look up another city
Look up another condition